Latest Regulatory News

Ovanti Limited launches its One Financial Superapp powered by Isentric, combining instant payments, DeFi yields, BNPL, and AI financial advisory in a unified platform targeting underbanked markets.

Viridis Mining and Minerals has raised AU$25 million through a heavily oversubscribed placement, bolstering its cash position to approximately AU$76 million as it advances the Colossus Rare Earth Project towards a Final Investment Decision in Q3 2026.

Biotron Limited reveals that its lead antiviral candidate BIT-HBV001 shows promising activity against Hepatitis Delta Virus, expanding its potential impact beyond Hepatitis B. Meanwhile, the company completes integration of Sedarex and advances regulatory plans for its anaesthetic SedRx.

OZZ Resources Limited has announced a fully underwritten entitlement offer to raise approximately $1.07 million, aiming to convert debt and fund project opportunities while addressing its ongoing ASX suspension. The offer carries significant risks including potential dilution and the threat of delisting if compliance is not met by June 2026.

Strike Resources has agreed to sell a further 28.52% indirect stake in its Apurimac Iron Ore Project to JE United Ltd for A$5.5 million, while securing a US$5 million credit facility to accelerate project development and iron ore marketing.

Imugene Limited has launched a $20 million equity raising comprising a $12 million placement and an $8 million Share Purchase Plan, alongside issuing options, convertible notes, and warrants to support its azer-cel clinical program.

Sequoia Financial Group is actively reviewing its retail licensee services, focusing on its subsidiary InterPrac Financial Planning, with potential structural changes or a sale under consideration amid shifting platform provider relationships.

Bank of Queensland Limited announces a fully franked quarterly distribution of AUD 1.3218 per Capital Note 3 security, payable mid-June 2026. The distribution reflects a 5.3% annualised rate tied to the 3-month BBSW plus margin.

Vulcan Energy has obtained its inaugural lithium production licence for the Lionheart Project in Germany, marking a pivotal step as the project moves into funded construction. This licence supports Vulcan’s ambition to supply Europe with sustainable lithium for electric vehicle batteries, backed by renewable energy co-production.

Ark Mines Limited has secured a crucial mining licence for its Sandy Mitchell Rare Earths Project in North Queensland, marking a key step toward development and commercialisation.

dorsaVi has secured significant commercial and clinical milestones with new elite sports and European clinical partnerships, showcasing its advanced real-time AI sensor technology.

Clarity Pharmaceuticals has unveiled compelling Phase II trial results showing its Cu-SAR-bisPSMA PET imaging agent significantly improves detection of prostate cancer recurrence over the current standard. The data, presented at the 2026 European Association of Urology Congress and accepted by European Urology journal, mark a key milestone ahead of regulatory submissions.